Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Two Diagnostic Tests in Patients With Suspected Invasive Candidiasis in Internal Medicine Wards and Who Are Currently Timely Treated With Micafungin

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years~* Patients giving their informed consent to participate to the study and to the use of their health data~* Patients with two or more SIRS criteria (hyperthermia, or hypothermia, tachycardia, tachypnea, leucocytosis or leukopenia )~* Patients treated with antibiotic therapy in the last 4 weeks and with central venous catheter~* Patients with at least one of these conditions ( cortisone therapy/ immunosuppressive agents, total parenteral nutrition, urinary catheter, anticancer chemotherapy and major surgery in the last 3 weeks, acute pancreatitis, diabetes mellitus, liver diseases, dialysis)~Exclusion Criteria:~* Patients with ALT, AST, bilirubin \> 3 times the upper limit of normal~* Patients enrolled in other interventional clinical studies~* Patients treated with echinocandin or azolic or polyene at the time of the enrolment~* Pregnancy or breastfeeding~* Neutropenic patients~* HIV positive patients~* Central nervous system events

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patients with suspicion of invasive candidiasis (Type: EXPERIMENTAL): Patients hospitalised in Internal Medicine with suspicion of invasive candidiasis will be treated with an echinocandin (micafungin) as timely as possible, and they will continue the antifungal treatment according to international guidelines when diagnosis is confirmed by positive 1,3-β-D-glucan test.

Based on this trial design, predict the completion outcome and termination type (if applicable).